PL2027140T3 - Przemysłowy sposób syntezy 17alfa-acetoksy-11beta-[4-(N,N-dimetyloamino)fenylo]-19-norpregna-4,9-dieno-3,20-dionu i nowe związki pośrednie sposobu - Google Patents
Przemysłowy sposób syntezy 17alfa-acetoksy-11beta-[4-(N,N-dimetyloamino)fenylo]-19-norpregna-4,9-dieno-3,20-dionu i nowe związki pośrednie sposobuInfo
- Publication number
- PL2027140T3 PL2027140T3 PL07733862T PL07733862T PL2027140T3 PL 2027140 T3 PL2027140 T3 PL 2027140T3 PL 07733862 T PL07733862 T PL 07733862T PL 07733862 T PL07733862 T PL 07733862T PL 2027140 T3 PL2027140 T3 PL 2027140T3
- Authority
- PL
- Poland
- Prior art keywords
- norpregna
- acetoxy
- dione
- diene
- beta
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0600491A HU227112B1 (hu) | 2006-06-14 | 2006-06-14 | Ipari eljárás 17-alfa-acetoxi-11-béta-[4-(N,N-dimetil-amino)-fenil]-19-norpregna-4,9-dién-3,20-dion elõállítására és új intermedierek az eljáráshoz |
EP07733862A EP2027140B1 (en) | 2006-06-14 | 2007-05-18 | Industrial process for the synthesis of 17 alpha -acetoxy-11 beta -[4-(n,n-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
PCT/HU2007/000045 WO2007144674A1 (en) | 2006-06-14 | 2007-05-18 | INDUSTRIAL PROCESS FOR THE SYNTHESIS OF 17α-ACETOXY-11β-[4-(N,N-DIMETHYL-AMINO)- PHENYL]-19-NORPREGNA-4,9-DIENE-3,20-DIONE AND NEW INTERMEDIATES OF THE PROCESS |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2027140T3 true PL2027140T3 (pl) | 2013-09-30 |
Family
ID=89986843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07733862T PL2027140T3 (pl) | 2006-06-14 | 2007-05-18 | Przemysłowy sposób syntezy 17alfa-acetoksy-11beta-[4-(N,N-dimetyloamino)fenylo]-19-norpregna-4,9-dieno-3,20-dionu i nowe związki pośrednie sposobu |
Country Status (22)
Country | Link |
---|---|
US (1) | US8110691B2 (pl) |
EP (1) | EP2027140B1 (pl) |
JP (1) | JP5274453B2 (pl) |
CN (1) | CN101466723B (pl) |
AR (1) | AR061052A1 (pl) |
AU (1) | AU2007258955B2 (pl) |
BR (1) | BRPI0713157A2 (pl) |
CA (1) | CA2653552C (pl) |
DK (1) | DK2027140T3 (pl) |
EA (1) | EA015302B1 (pl) |
ES (1) | ES2409841T3 (pl) |
HU (1) | HU227112B1 (pl) |
IL (1) | IL195253A (pl) |
MX (1) | MX2008015972A (pl) |
NO (1) | NO341620B1 (pl) |
PL (1) | PL2027140T3 (pl) |
PT (1) | PT2027140E (pl) |
RS (1) | RS52758B (pl) |
SI (1) | SI2027140T1 (pl) |
UA (1) | UA94269C2 (pl) |
WO (1) | WO2007144674A1 (pl) |
ZA (1) | ZA200809799B (pl) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102241722B (zh) * | 2010-05-12 | 2015-11-25 | 杭州容立医药科技有限公司 | 一种合成孕酮受体调节剂优力司特的纯化方法 |
CN102372760A (zh) * | 2010-08-12 | 2012-03-14 | 杭州容立医药科技有限公司 | 一种合成孕酮受体调节剂优力司特的合成方法 |
CN102477060B (zh) * | 2010-11-22 | 2014-08-13 | 华润紫竹药业有限公司 | 甾体化合物及其制备方法和用途 |
CN102516345B (zh) * | 2011-11-01 | 2014-11-26 | 上海优拓医药科技有限公司 | 醋酸乌利司他及其关键中间体的制备方法 |
CN102617692A (zh) * | 2011-01-31 | 2012-08-01 | 北京紫竹药业有限公司 | 甾体化合物及其制备方法和用途 |
CN102295674B (zh) * | 2011-07-14 | 2013-04-10 | 四川大学 | 获得高纯度17α-乙酰氧基-11β-(4-N,N-二甲氨基苯基)-19-去甲孕甾-4,9-二烯-3,20-二酮的方法 |
CN102344478B (zh) * | 2011-07-22 | 2013-08-07 | 上海希迈医药科技有限公司 | 一种17α-乙酰氧基-11β-(4-N,N-二甲氨基苯基)-19-去甲孕甾-4,9-二烯-3,20-二酮的结晶物及其制备方法 |
CN102321141B (zh) * | 2011-07-22 | 2013-05-15 | 上海希迈医药科技有限公司 | 一种17α-乙酰氧基-11β-(4-N,N-二甲氨基苯基)-19-去甲孕甾-4,9-二烯-3,20-二酮的无定形物及其制备方法 |
CN103193850A (zh) * | 2012-01-04 | 2013-07-10 | 北京紫竹药业有限公司 | 甾体化合物的新晶型及其制备方法 |
CN104628806A (zh) * | 2012-01-19 | 2015-05-20 | 华润紫竹药业有限公司 | 甾体化合物及其制备方法和用途 |
CN103755765B (zh) * | 2012-04-17 | 2018-01-02 | 常州市第四制药厂有限公司 | 醋酸乌利司他的多晶型及其制备方法 |
CN102675395B (zh) * | 2012-04-17 | 2014-04-30 | 常州市第四制药厂有限公司 | 醋酸乌利司他的多晶型及其制备方法 |
CN102702296B (zh) * | 2012-06-19 | 2014-09-03 | 山东诚创医药技术开发有限公司 | 环-3,20-双(1,2-亚乙基缩醛)-17α-羟基-17β-乙酰基-雌甾-5(10),9(11)-二烯-3-酮的制备方法 |
JP2015532263A (ja) | 2012-09-28 | 2015-11-09 | あすか製薬株式会社 | ウリプリスタール酢酸エステルの結晶多形 |
JP6200493B2 (ja) | 2012-09-28 | 2017-09-20 | あすか製薬株式会社 | 無定形ウリプリスタール酢酸エステル |
AU2013321890B2 (en) | 2012-09-28 | 2017-05-18 | Aska Pharmaceutical Co., Ltd. | Crystalline polymorphic form of ulipristal acetate |
CN102875629B (zh) * | 2012-10-10 | 2014-11-19 | 苏州康润医药有限公司 | 醋酸乌利司他的合成方法 |
WO2014060888A1 (en) * | 2012-10-18 | 2014-04-24 | Lupin Limited | Novel process and intermediate for preparation of ulipristal |
CN102942612A (zh) * | 2012-10-30 | 2013-02-27 | 四川大学 | 一种合成醋酸乌利司他的新方法 |
CN103804456B (zh) * | 2012-11-15 | 2017-08-04 | 上海创诺医药集团有限公司 | 醋酸乌利司他中间体及其制备方法 |
CN103145787B (zh) * | 2012-12-25 | 2017-02-22 | 常州市亚邦医药研究所有限公司 | 制备醋酸优力司特关键中间体的新方法 |
CN103087140A (zh) * | 2013-03-04 | 2013-05-08 | 四川尚锐生物医药有限公司 | 一种醋酸优力司特多晶型的制备方法 |
CN103145788B (zh) * | 2013-03-25 | 2015-08-19 | 浙江仙琚制药股份有限公司 | 醋酸优力司特关键中间体的制备方法 |
HU230319B1 (hu) | 2013-10-01 | 2016-01-28 | Richter Gedeon Nyrt. | Ipari eljárás szteroid hatóanyagok előállítására |
CN103755763A (zh) * | 2013-12-30 | 2014-04-30 | 烟台东诚生化股份有限公司 | 17α-乙酰氧基-11β-[4-(N,N-二甲基氨基)-苯基]-19-去甲孕甾-4,9-二烯-3,20-二酮的制备方法 |
CN104530169B (zh) * | 2014-12-12 | 2017-09-12 | 成都化润药业有限公司 | 一种醋酸乌利司他及其中间体的制备方法 |
CN106986908B (zh) * | 2017-03-23 | 2019-05-10 | 湖南玉新药业有限公司 | 倍他米松的制备方法 |
CN106986911B (zh) * | 2017-03-23 | 2019-05-10 | 湖南玉新药业有限公司 | ***关键中间体联烯亚砜物的制备方法 |
CN108558982A (zh) * | 2018-05-21 | 2018-09-21 | 郑州泰丰制药有限公司 | 一种新型醋酸乌利司他以及其生产制造方法 |
CN109053846B (zh) * | 2018-08-14 | 2020-01-07 | 台州仙琚药业有限公司 | 制备醋酸优力司特双缩酮的方法 |
CN111349137A (zh) * | 2018-12-21 | 2020-06-30 | 北京启慧生物医药有限公司 | 一种绿色合成醋酸乌利司他中间体及醋酸乌利司他的方法 |
CN110256519B (zh) * | 2019-05-23 | 2021-06-08 | 江苏联环药业股份有限公司 | 一锅法制备醋酸乌利司他的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4041055A (en) * | 1975-11-17 | 1977-08-09 | The Upjohn Company | Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes |
US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
US5929262A (en) * | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
US6768014B2 (en) * | 1999-12-29 | 2004-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | PROCESS FOR PREPARING 17α-ACETOXY-11β-[4-N,N(DIMETHYLAMINO)PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIENE-3,20-DIONE, INTERMEDIATES USEFUL IN THE PROCESS , AND PROCESSES FOR PREPARING SUCH INTERMEDIATES |
US6512130B1 (en) * | 2000-09-05 | 2003-01-28 | Council Of Scientific And Industrial Research | Mifepristone analogue, process for the preparation thereof and use thereof |
AU2004217988C1 (en) * | 2003-02-28 | 2010-06-03 | Southwest Foundation For Biomedical Research | Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
FR2854403B1 (fr) * | 2003-04-29 | 2008-07-11 | Aventis Pharma Sa | Nouveau procede et intermediaires de preparation de composes 19-nor-steroides 17-halogenes |
HUP0301332A3 (en) * | 2003-05-14 | 2006-04-28 | Richter Gedeon Vegyeszet | New mono-and bismethylene steroid derivatives and process for their synthesis and pharmaceutical compositions containing them |
ITMI20042001A1 (it) * | 2004-10-21 | 2005-01-21 | Ind Chimica Srl | Processo per la preparazione di 21-idrossi steroidi con controllo della distribuzione epimerica nella posizione c-21 |
-
2006
- 2006-06-14 HU HU0600491A patent/HU227112B1/hu not_active IP Right Cessation
-
2007
- 2007-05-18 AU AU2007258955A patent/AU2007258955B2/en not_active Ceased
- 2007-05-18 RS RS20130179A patent/RS52758B/en unknown
- 2007-05-18 US US12/303,160 patent/US8110691B2/en not_active Expired - Fee Related
- 2007-05-18 UA UAA200900274A patent/UA94269C2/ru unknown
- 2007-05-18 BR BRPI0713157-7A patent/BRPI0713157A2/pt not_active Application Discontinuation
- 2007-05-18 JP JP2009514916A patent/JP5274453B2/ja not_active Expired - Fee Related
- 2007-05-18 EA EA200900015A patent/EA015302B1/ru not_active IP Right Cessation
- 2007-05-18 PT PT77338622T patent/PT2027140E/pt unknown
- 2007-05-18 CN CN2007800219159A patent/CN101466723B/zh not_active Expired - Fee Related
- 2007-05-18 SI SI200731232T patent/SI2027140T1/sl unknown
- 2007-05-18 EP EP07733862A patent/EP2027140B1/en active Active
- 2007-05-18 ES ES07733862T patent/ES2409841T3/es active Active
- 2007-05-18 WO PCT/HU2007/000045 patent/WO2007144674A1/en active Application Filing
- 2007-05-18 DK DK07733862.2T patent/DK2027140T3/da active
- 2007-05-18 PL PL07733862T patent/PL2027140T3/pl unknown
- 2007-05-18 CA CA2653552A patent/CA2653552C/en not_active Expired - Fee Related
- 2007-05-18 MX MX2008015972A patent/MX2008015972A/es active IP Right Grant
- 2007-05-21 AR ARP070102187A patent/AR061052A1/es active IP Right Grant
-
2008
- 2008-11-12 IL IL195253A patent/IL195253A/en active IP Right Grant
- 2008-11-17 ZA ZA200809799A patent/ZA200809799B/xx unknown
-
2009
- 2009-01-13 NO NO20090196A patent/NO341620B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SI2027140T1 (sl) | 2013-07-31 |
IL195253A0 (en) | 2009-08-03 |
ES2409841T3 (es) | 2013-06-28 |
DK2027140T3 (da) | 2013-06-03 |
ZA200809799B (en) | 2009-11-25 |
CA2653552C (en) | 2013-04-23 |
IL195253A (en) | 2011-11-30 |
EA015302B1 (ru) | 2011-06-30 |
PT2027140E (pt) | 2013-06-04 |
MX2008015972A (es) | 2009-01-12 |
HU0600491D0 (en) | 2006-08-28 |
NO20090196L (no) | 2009-03-10 |
AU2007258955A1 (en) | 2007-12-21 |
CA2653552A1 (en) | 2007-12-21 |
JP5274453B2 (ja) | 2013-08-28 |
CN101466723A (zh) | 2009-06-24 |
UA94269C2 (en) | 2011-04-26 |
JP2009539964A (ja) | 2009-11-19 |
US20090187032A1 (en) | 2009-07-23 |
CN101466723B (zh) | 2011-11-02 |
NO341620B1 (no) | 2017-12-11 |
AU2007258955B2 (en) | 2012-09-20 |
HU227112B1 (hu) | 2010-07-28 |
RS52758B (en) | 2013-08-30 |
EP2027140A1 (en) | 2009-02-25 |
HUP0600491A2 (en) | 2008-02-28 |
AR061052A1 (es) | 2008-07-30 |
BRPI0713157A2 (pt) | 2012-04-03 |
WO2007144674A1 (en) | 2007-12-21 |
US8110691B2 (en) | 2012-02-07 |
EP2027140B1 (en) | 2013-03-13 |
EA200900015A1 (ru) | 2009-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2027140T3 (pl) | Przemysłowy sposób syntezy 17alfa-acetoksy-11beta-[4-(N,N-dimetyloamino)fenylo]-19-norpregna-4,9-dieno-3,20-dionu i nowe związki pośrednie sposobu | |
ZA200907030B (en) | Industrial method for the synthesis of 17-acetoxy-11²-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process | |
HK1081945A1 (en) | Process for the synthesis of 4,5-dimethoxy-1-(methylaminomethyl)-benzocy clobutane, and the use thereof | |
IL197161A (en) | Derivatives 4- (n-azacycloalkyl) anilides Preparations containing and using them | |
IL192241A (en) | A process for making 4 - (benzimidazolylmethylamino) - benzamides and their salts | |
IL184694A0 (en) | New polymorphous forms of rifazimin, processes for their production and use thereof in the medicinal | |
PL1896364T3 (pl) | Proszkowa kompozycja wapna, sposób jej wytwarzania i jej zastosowanie | |
EP2070935A4 (en) | NOVEL COMPOUND, COMPOSITION COMPRISING SAME, AND PROCESS FOR PRODUCING POLYMERIZABLE AMIDE | |
ZA201105102B (en) | Process for the synthesis of l-fucosyl di-or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof | |
EP1916241A4 (en) | CRYSTAL OF A PHENYLALANINE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND ITS USE | |
IL234893A (en) | A process for making derivatives of piperazine and diazepanyl benzamide | |
EP2137152A4 (en) | NEW BENZAMIDE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
PL1977021T3 (pl) | Przystosowana do dużych obciążeń kompozycja materiałowa zawierająca Sn; sposób wytwarzania przystosowanej do dużych obciążeń powłoki i jej zastosowanie | |
EP1992613A4 (en) | PROCESS FOR PRODUCTION OF 3,4-DISUBSTITUTED PYRROLIDINE DERIVATIVE AND INTERMEDIATE PRODUCTION METHOD | |
PL1937626T3 (pl) | Sposób i związki do otrzymywania salmeterolu | |
PL1783105T3 (pl) | Kompozycja zaprawowa, sposób jej wytwarzania i jej zastosowanie | |
ZA201000394B (en) | Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds | |
IL197876A0 (en) | N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression | |
HK1119953A1 (en) | Process for the stereoselective preparation of (-)-halofenate and intermediates thereof | |
EP2049580B8 (de) | Selbstdispergierbare silikoncopolymerisate und verfahren zu deren herstellung und deren verwendung | |
ZA200909033B (en) | Unshaped refractory material, a process for producing an earth-moist, unshaped refractory material, and use of the unshaped refractory material | |
AP2376A (en) | A novel process for the manufacture of 5-nonyl salicylaldoxime. | |
EP2011781A4 (en) | METHOD FOR SYNTHESIZING AN INDENE DERIVATIVE AND INTERMEDIATE FOR SYNTHESIS OF SAID DERIVATIVE | |
PL2044269T3 (pl) | Materiał budowlany jak również sposób jego wytwarzania i zastosowanie materiału budowlanego | |
EP1854844A4 (en) | POLYANILINE CONTAINING COMPOSITION AND PROCESS FOR PRODUCING THE SAME |